Cell Biotech Co

Cell Biotech Co Debt

The Debt of Cell Biotech Co (049960.KQ) as of Oct 10, 2026 is 366.66 M KRW. In the previous year, Debt was 934.17 M KRW — a change of -60.75% (lower).

Debt

366.66 MKRW

YoY

-60.75%

Last updated:

In 2024, Cell Biotech Co's total debt was 366.66 M KRW, a -60.75% change from the 934.17 M KRW total debt recorded in the previous year.

The Cell Biotech Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
0.00 KRW
Jan 1, 2018
0.00 KRW
Jan 1, 2019
512.08 M KRW
Jan 1, 2020
686.44 M KRW
Jan 1, 2021
423.49 M KRW
Jan 1, 2022
357.79 M KRW
Jan 1, 2023
934.17 M KRW
Jan 1, 2024
366.66 M KRW
The Cell Biotech Co Debt history
YEARDebtYoY
366.66 MKRW-60.75%
934.17 MKRW+161.09%
357.79 MKRW-15.51%
423.49 MKRW-38.31%
686.44 MKRW+34.05%
512.08 MKRW—
0.00KRW—
0.00KRW—
0.00KRW—
Access this data via the Eulerpool API
Get Free API Key

Cell Biotech Co Stock analysis

What does Cell Biotech Co do? Cell Biotech Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding Cell Biotech Co's Debt Structure

Cell Biotech Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Cell Biotech Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Cell Biotech Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Cell Biotech Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Cell Biotech Co stock

Debt of Cell Biotech Co is 366.66 M KRW in 2024.

Debt of Cell Biotech Co changed from 934.17 M KRW to 366.66 M KRW, representing a -60.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Cell Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Cell Biotech Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Cell Biotech Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Cell Biotech Co